Enantioselective synthesis of adamantylalanine and carboranylalanine and their incorporation into the proteasome inhibitor bortezomib

A Set of Activity-Based Probes to Visualize Human (Immuno)proteasome Activities

(2015) Gerjan de Bruin et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Structure-Based Design of β1i or β5i Specific Inhibitors of Human Immunoproteasomes

(2014) Gerjan de Bruin et al.   JOURNAL OF MEDICINAL CHEMISTRY

Critical review, with an optimistic outlook, on Boron Neutron Capture Therapy (BNCT)

(2013) Raymond L. Moss   APPLIED RADIATION AND ISOTOPES

Clinical and Marketed Proteasome Inhibitors for Cancer Treatment

(2013) Jiankang Zhang et al.   CURRENT MEDICINAL CHEMISTRY

Immuno- and Constitutive Proteasome Crystal Structures Reveal Differences in Substrate and Inhibitor Specificity

(2012) Eva M. Huber et al.   CELL

A Carborane-Derivative “Click” Reaction under Heterogeneous Conditions for the Synthesis of a Promising Lipophilic MRI/GdBNCT Agent

(2012) Antonio Toppino et al.   CHEMISTRY-A EUROPEAN JOURNAL

Carbaboranes as Pharmacophores: Properties, Synthesis, and Application Strategies

(2011) Matthias Scholz et al.   CHEMICAL REVIEWS

Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer

(2010) E. Kupperman et al.   CANCER RESEARCH

Synthesis and Applications oftert-Butanesulfinamide

(2010) MaryAnn T. Robak et al.   CHEMICAL REVIEWS

A convergent approach to synthesis of bortezomib: the use of TBTU suppresses racemization in the fragment condensation

(2009) Andrey S. Ivanov et al.   TETRAHEDRON